Pulmonary fibrosis: Tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT

Diagnostic and Interventional Radiology

Volumn 23, Issue 2, 2017, Pages 106-111

  Lavelle, Lisa P ^a   Brady, Darragh ^a   McEvoy, Sinead ^a   Murphy, David ^a   Gibney, Brian ^a   Gallagher, Annika ^a   Butler, Marcus ^a   Shortt, Fionnula ^b   McMullen, Marie ^b   Fabre, Aurelie ^a   Lynch, David A ^c   Keane, Michael P ^a   Dodd, Jonathan D ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b St Vincent's Private Hospital   (Ireland)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GADOTERATE MEGLUMINE;

ADULT; AGED; ARTERIAL BLOOD; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC RADIOLOGIST; DISEASE DURATION; DISEASE SEVERITY ASSESSMENT; ELECTROCARDIOGRAM; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FIBROSIS; MALE; MEDICAL RESEARCH DYSPNEA SCALE SCORE; MEDICAL SOCIETY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY ARTERY; SCORING SYSTEM; SEQUENCE ANALYSIS; SPIROMETRY; TISSUE CHARACTERIZATION; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; IMAGE ENHANCEMENT; METABOLISM; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PULMONARY FIBROSIS; RADIOGRAPHIC IMAGE ENHANCEMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85014365075     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.5152/dir.2016.15331     Document Type: Article

References (28)

1. Lynch DA, Godwin JD, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172:488–493.
2. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788–824.
3. Raghu G, Lynch D, Godwin JD, et al. Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial. Lancet Respir Med 2014; 2:277–284.
4. Raghu G. Idiopathic pulmonary fibrosis: new evidence and an improved standard of care in 2012. Lancet 2012; 380:699–701.
5. Corteville DMR, Kjørstad A, Henzler T, Zöllner FG, Schad LR. Fourier decomposition pulmonary MRI using a variable flip angle balanced steady-state free precession technique. Magn Reson Med 2015; 73:1999–2004.
6. Rajaram S, Swift AJ, Capener D, et al. Lung morphology assessment with balanced steady-state free precession MR imaging compared with CT. Radiology 2012; 263:569–577.
7. Ohno Y, Nishio M, Koyama H, et al. Pulmonary MR imaging with ultra-short TEs: utility for disease severity assessment of connective tissue disease patients. Eur J Radiol 2013; 82:1359–1365.
8. Seki S, Koyama H, Ohno Y, et al. Diffusion-weighted MR imaging vs. multi-detector row CT: Direct comparison of capability for assessment of management needs for anterior mediastinal solitary tumors. Eur J Radiol 2014; 83:835–842.
9. Ackman JB, Wu CC, Halpern EF, Abbott GF, Shepard J-AO. Nonvascular thoracic magnetic resonance imaging: the current state of training, utilization, and perceived value: survey of the society of thoracic radiology membership. J Thorac Imaging 2014; 29:252–257.
10. Kim RJ, Albert TS, Wible JH, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation 2008; 117:629–637.
11. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445–1453.
12. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003; 5:505–514.
13. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218:215–223.
14. Kim RJ. Cardiovascular MRI. Philadelphia: WB Saunders Company; 2007.
15. O’Donnell DH, Abbara S, Chaithiraphan V, et al. Cardiac MR imaging of nonischemic cardiomyopathies: imaging protocols and spectra of appearances. Radiology 2012; 262:403–422.
16. Desai SR, Veeraraghavan S, Hansell DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004; 232:560–567.
17. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246:697–722.
18. Smulders MW, Bekkers SCAM, Kim HW, Van Assche LMR, Parker MA, Kim RJ. Performance of CMR methods for differentiating acute from chronic MI. JACC Cardiovasc Imaging 2015; 8:669–679.
19. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
20. Kendall RT, Feghali-Bostwick CA. Fibroblasts in fibrosis: novel roles and mediators. Front Pharmacol 2014; 5:123.
21. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100:1992–2002.
22. Verrecchia F, Mauviel A. Transforming growth factor-beta and fibrosis. World J Gastroenterol 2007; 13:3056–3062.
23. Hoyles RK, Derrett-Smith EC, Khan K, et al. An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor. Am J Respir Crit Care Med 2011; 183:249–261.
24. Euler-Taimor G, Heger J. The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res 2006; 69:15–25.
25. King MA, Bergin CJ, Ghadishah E, Yi ES, Clark JB. Detecting pulmonary abnormalities on magnetic resonance images in patients with usual interstitial pneumonitis: effect of varying window settings and gadopentetate dimeglumine. Acad Radiol 1996; 3:300–307.
26. Gaeta M, Blandino A, Scribano E, et al. Chronic infiltrative lung diseases: value of gadolinium-enhanced MRI in the evaluation of disease activity--early report. Chest 2000; 117:1173– 1178.
27. Yi CA, Lee KS, Han J, Chung MP, Chung MJ, Shin KM. 3-T MRI for differentiating inflammationand fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation. AJR Am J Roentgenol 2008; 190:878–885.
28. Akira M, Inoue Y, Kitaichi M, Yamamoto S, Arai T, Toyokawa K. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251:271–279.